Invasive Non-Aspergillus Mold Infections in Transplant Recipients, United States, 2001–2006
Benjamin J. Park , Peter G. Pappas, Kathleen A. Wannemuehler, Barbara D. Alexander, Elias J. Anaissie, David R. Andes, John W. Baddley, Janice M. Brown, Lisa M. Brumble, Alison G. Freifeld, Susan Hadley, Loreen Herwaldt, James I. Ito, Carol A. Kauffman, G. Marshall Lyon, Kieren A. Marr, Vicki A. Morrison, Genovefa Papanicolaou, Thomas F. Patterson, Trish M. Perl, Mindy G. Schuster, Randall Walker, John R. Wingard, Thomas J. Walsh, and Dimitrios P. Kontoyiannis
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (B.J. Park, K.A. Wannemuehler); University of Alabama at Birmingham Medical Center, Birmingham, Alabama, USA (P.G. Pappas, J.W. Baddley); Duke University Medical Center, Durham, North Carolina, USA (B.D. Alexander); University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA (E.J. Anaissie); University of Wisconsin–Madison, Madison, Wisconsin, USA (D.R. Andes); Stanford University School of Medicine, Stanford, California, USA (J.M. Brown); Mayo Clinic, Jacksonville, Florida, USA (L.M. Brumble); University of Nebraska Medical Center, Omaha, Nebraska, USA (A.G. Freifeld); Tufts Medical Center, Boston, Massachusetts, USA (S. Hadley); University of Iowa Hospital, Iowa City, Iowa, USA (L. Herwaldt); City of Hope National Medical Center, Duarte, California, USA (J.I. Ito); University of Michigan, Ann Arbor, Michigan, USA (C.A. Kauffman); Veterans Affairs Ann Arbor Healthcare System–Medicine, Ann Arbor (C.A. Kauffman); Emory University School of Medicine, Atlanta (G.M. Lyon); Johns Hopkins Medical Institutions, Baltimore, Maryland, USA (K.A. Marr, T.M. Perl); Fred Hutchinson Cancer Research Center, Seattle, Washington, USA (K.A. Marr); University of Minnesota, Minneapolis, Minnesota, USA (V.A. Morrison); Veterans Affairs Medical Center, Minneapolis (V.A. Morrison); Memorial Sloan Kettering Cancer Center, New York, New York, USA (G. Papanicolaou); University of Texas Health Sciences Center, San Antonio, Texas, USA (T.F. Patterson); South Texas Veterans Healthcare System, San Antonio (T.F. Patterson); Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA (M.G. Schuster); Mayo Clinic, Rochester, Minnesota, USA (R. Walker); University of Florida, Gainesville, Florida, USA (J.R. Wingard); National Institutes of Health, Bethesda, Maryland, USA (T.J. Walsh); MD Anderson Cancer Center, Houston, Texas, USA (D.P. Kontoyiannis)
Figure 2. Twelve-month cumulative incidence for invasive A) Mucorales infections and B) combined Fusarium and Scedosporium spp. infections among donor types of hematopoietic cell transplant recipients reported in the Transplant-Associated Infection Surveillance Network, United States 2001–2006. Infection data by transplant type: allogenic URD, 2,483 patients, 20 with Mucorales infection, 9 with Fusarium or Scedosporium spp. infection; allogenic MRD, 3,499 patients, 19 with Mucorales infection, 11 with Fusarium or Scedosporium spp. infection; allogenic MMR, 427 patients, 1 with Mucorales infection, 2 with Fusarium or Scedosporium spp. infection; autologous, 9,326 patients, 4 with Mucorales infection, 2 with Fusarium or Scedosporium spp. infection; overall, 15,820 patients, 44 with Mucorales infection, 24 with Fusarium or Scedosporium spp. infection. URD, unrelated donor; MRD, matched related donor; MMR, mismatched related donor.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.